Kenya has taken a major step in its fight against HIV after receiving its first shipment of 21,000 starter doses of lenacapavir, a breakthrough long-acting injectable for HIV pre-exposure prophylaxis (PrEP).
The arrival of the consignment signals a significant boost to the country’s HIV prevention strategy, positioning Kenya among the first nations in East Africa to introduce the innovative drug.
…CONTINUE READING